Cargando…
MiR‐590 Promotes Transdifferentiation of Porcine and Human Fibroblasts Toward a Cardiomyocyte‐Like Fate by Directly Repressing Specificity Protein 1
BACKGROUND: Reprogramming of cardiac fibroblasts into induced cardiomyocyte‐like cells represents a promising potential new therapy for treating heart disease, inducing significant improvements in postinfarct ventricular function in rodent models. Because reprogramming factors effective in transdiff...
Autores principales: | Singh, Vivek P., Mathison, Megumi, Patel, Vivekkumar, Sanagasetti, Deepthi, Gibson, Brian W., Yang, Jianchang, Rosengart, Todd K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210349/ https://www.ncbi.nlm.nih.gov/pubmed/27930352 http://dx.doi.org/10.1161/JAHA.116.003922 |
Ejemplares similares
-
Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming
por: Singh, Vivek P., et al.
Publicado: (2021) -
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation
por: Pinnamaneni, Jaya Pratap, et al.
Publicado: (2022) -
Enhanced Generation of Induced Cardiomyocytes Using a Small‐Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming
por: Singh, Vivek P., et al.
Publicado: (2020) -
Fibroblast transition to an endothelial “trans” state improves cell reprogramming efficiency
por: Mathison, Megumi, et al.
Publicado: (2021) -
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis
por: Yang, Lina, et al.
Publicado: (2017)